Beneficial Effects of O-GlcNAc Stimulation in a Young Rat Model of Sepsis: Beyond Modulation of Gene Expression
Authors:
- Thomas DupasTDThomas Dupas
- Antoine PerselloAPAntoine Persello
- Angélique Blangy-LetheuleABAngélique Blangy-Letheule
- Manon DenisMDManon Denis
- Angélique ErraudAEAngélique Erraud
- Virginie AillerieVAVirginie Aillerie
- Aurélia A. LerouxALAurélia A. Leroux
- Matthieu RivièreMRMatthieu Rivière
- Jacques LebretonJacques Lebreton
- Arnaud TessierATArnaud Tessier
- Bertrand RozecBRBertrand Rozec
- Benjamin LauzierBLBenjamin Lauzier
Open Access
- 9 June 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6430
Abstract
The young population, which is particularly at risk of sepsis, is, paradoxically, rarely studied. Acute stimulation of O-GlcNAcylation, a post-translational modification involved in metabolic regulation, cell survival and stress response, is beneficial in young rats with sepsis. Considering that sepsis impacts the gene expression profile and that O-GlcNAcylation is a regulator of transcription, the aims of this study are to (i) unveil beneficial mechanisms of O-GlcNAcylation and (ii) decipher the relationship between O-GlcNAcylation and transcription during sepsis. Endotoxemic challenge was induced in 28-day-old male rats using a lipopolysaccharide injection (E. coli O111:B4, 20 mg·kg−1) and compared to control rats (NaCl 0.9%). One hour after, rats were assigned to no therapy or fluidotherapy (NaCl 0.9%, 10 mL.kg−1) ± NButGT (10 mg·kg−1) to stimulate O-GlcNAc levels. Cardiac O-GlcNAcylation levels were evaluated via Western blot and gene transcription using 3′ SRP analysis. Lipopolysaccharide injection favorizes inflammatory state with the overexpression of genes involved in the NF-κB, JAK/STAT and MAPK pathways. NButGT treatment increased cardiac O-GlcNAcylation levels (p < 0.05). Yet, the mRNA expression was not impacted two hours after fluidotherapy or NButGT treatment. In conclusion, O-GlcNAc stimulation-induced beneficial effects are not dependent on the gene expression profile at the early phase of sepsis.Keywords
Funding Information
- Société Française d’Anesthésie et de Réanimation (20-ASTC-0032-01-hErOiSmE)
- Fondation d’entreprises Genavie (20-ASTC-0032-01-hErOiSmE)
- Fédération Française de Cardiologie (20-ASTC-0032-01-hErOiSmE)
- Agence Nationale de la Recherche (20-ASTC-0032-01-hErOiSmE)
- Direction Générale de l’Armement (20-ASTC-0032-01-hErOiSmE)
- Region des Pays de la Loire (20-ASTC-0032-01-hErOiSmE)
- InFlectis BioScience (20-ASTC-0032-01-hErOiSmE)
This publication has 62 references indexed in Scilit:
- Genomic responses in mouse models poorly mimic human inflammatory diseasesProceedings of the National Academy of Sciences, 2013
- Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouseDisease Models & Mechanisms, 2013
- Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsisClinical Science, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Comparison of Sepsis-Induced Transcriptomic Changes in a Murine Model to Clinical Blood Samples Identifies Common Response PatternsFrontiers in Microbiology, 2012
- Inhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 AdipocytesChemistry & Biology, 2010
- Serum Soluble ICAM-1, VCAM-1, L-Selectin, and P-Selectin Levels as Markers of Infection and their Relation to Clinical Severity in Neonatal SepsisAmerican Journal of Perinatology, 2007
- NF-κB activation as a pathological mechanism of septic shock and inflammationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- O-GlcNAcase Uses Substrate-assisted CatalysisJournal of Biological Chemistry, 2005
- Nuclear Factor–κB and Its Role in Sepsis‐Associated Organ FailureThe Journal of Infectious Diseases, 2003